CSIMarket Company Name, Ticker, Customers, else..
 
Aura Biosciences Inc   (AURA)
Other Ticker:  
 
 

Aura Biosciences Inc Income Statement Quarterly

AURA


Select the Financial Report:   Period:   Fiscal Year:

New: More AURA's historic Income Statements >>

INCOME STATEMENT
(Quarterly GAAP In millions $)

 (Jun 30 2023)
II. Quarter		 (Mar 31 2023)
I. Quarter		 (Dec 31 2022)
IV. Quarter		 (Sep 30 2022)
III. Quarter		 (Jun 30 2022)
II. Quarter
Fair Value Adjustment Of Warrants - - - 0.06
Change In Fair Value Of Derivative Liability - - - -
Other Revenue - - - -0.06
Total Revenue 0.00 0.00 0.00 0.00 0.00
Cost of Revenues - - - - -
Provision for Loan, Lease, and Other Losses 2.01 1.99 1.06 0.48 0.29
Gross Profit -2.01 -1.99 -1.06 -0.48 -0.29
Selling, Administration, Marketing 5.16 5.04 4.45 4.76 4.31
Gain (Loss) on Disposition of Assets - - - -0.31 -
Depriciation & Amortization - - - - -
Research and Development Expense 15.12 14.41 13.16 11.29 9.51
Restructuring, Accretion & impairment charges - - - - -
Other operatinig exp. /-income -2.01 -1.99 -1.06 -0.17 -0.29
Unusual Expense /-Income - - - - -
Total operating costs including COS 20.28 19.44 17.61 16.06 13.82
Operating income/-loss -20.28 -19.44 -17.61 -16.06 -13.82
Other Deductions / - Income
Interest expense - - - - -
Interest income - - - - -
Net interest expense/-income - - - - -
Gain (Loss) on Investments - - - -0.01 -
Foreign Currency Transaction (Gain) Loss - - - - -
Allowances, Health Care Trust Fund And Other - - - - -
Unexpected (Gain) Loss - - - - -
Other loss/ -income -1.98 -1.98 -1.05 -0.15 -0.35
Total costs & expenses 18.30 17.47 16.56 15.90 13.47
Income /-loss before income taxes -18.30 -17.47 -16.56 -15.90 -13.47
Income taxes expenses/-benefit - - - - -
Income after income taxes -18.30 -17.47 -16.56 -15.90 -13.47
Net income/-loss of other equity - - - - -
Income/-loss from cont. Ops. -18.30 -17.47 -16.56 -15.90 -13.47
Accounting change - - - - -
Discontinued operations - - - - -
Extraordinary items - - - - -
Net Income/-loss -18.30 -17.47 -16.56 -15.90 -13.47
Noncontrolling interests - - - - -
Prefered dividends - - - - -
Other - - - - -
Income/-loss to shareholder -18.30 -17.47 -16.56 -15.90 -13.47
EBIT -18.30 -17.47 42.20 -15.90 -13.47
EBITD -18.00 -17.14 41.35 -15.60 -13.17
EBITDA -18.00 -17.14 41.35 -15.60 -13.17


Per Share (GAAP Quarterly, in $) (Jun 30 2023)
II. Quarter		 (Mar 31 2023)
I. Quarter		 (Dec 31 2022)
IV. Quarter		 (Sep 30 2022)
III. Quarter		 (Jun 30 2022)
II. Quarter
Basic EPS (excl. extra items) -0.48 -0.46 -0.52 -0.54 -0.46
   Extraordinary items 0.00 0.00 0.00 0.00 0.00
Basic Net EPS -0.48 -0.46 -0.52 -0.54 -0.46
Basic shares outstanding (Mill. of Units) 37.86 37.78 32.01 29.27 29.25
   EPS other shares - - - - -
Diluted Net EPS -0.48 -0.46 -0.27 -0.54 -0.46
Diluted average shares (Mill. of Units) 37.86 37.78 29.98 29.27 29.25
Dividend per share - - - - -



Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2023 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com